Opportunities center on NPPT-coated and blended urea, nitrogen stabilizers, controlled-release products, and climate-smart formulations with emissions verification. Asia-Pacific offers strong ...
Trials of current B cell-directed therapies and an investigational inhibitor of the alternative complement pathway demonstrate proteinuria reduction in patients with IgA nephropathy. Targeting ...
What Is Skyrizi, and Why Does It Matter? Skyrizi (risankizumab-rzaa) is a prescription biologic used to treat certain immune-mediated inflammatory conditions. It is now approved by the FDA for ...
For patients with advanced solid tumors harboring specific genetic alterations, the first-in-class synthetic lethal combination of WEE1 inhibitor zedoresertib plus PKMYT1 inhibitor lunresertib ...
FDA authorization covers moderate-to-severe plaque psoriasis in adults and patients aged ≥12 years, expanding systemic options for adolescents. Icotrokinra is characterized as a first-in-class ...
Although many things can affect your individual prognosis, about half of all patients will reach kidney failure within 10 years of their diagnosis and need dialysis or a kidney transplant. Even after ...
What Is Sotyktu, and Why Does It Matter? Sotyktu (deucravacitinib) is an oral selective tyrosine kinase 2 (TYK2) inhibitor used to treat autoimmune inflammatory diseases such as plaque psoriasis in ...
The factor XIa inhibitor, asundexian (Bayer), has finally achieved the holy grail of reducing thrombotic events without increasing bleeding. In the OCEANIC-STROKE trial, conducted in patients with ...
Enlicitide decanoate, an oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; longer-term data ...
ABSTRACT: In Campeche Mexico, corn production is particularly very important due to its large area of medium and high-yield potential. For any plan production, soil fertility needs to be understood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results